Rxo (RXO) Asset Writedowns and Impairment (2024 - 2026)

Rxo (RXO) has 3 years of Asset Writedowns and Impairment data on file, last reported at $4.0 million in Q1 2026.

• Quarterly Asset Writedowns and Impairment changed 0.0% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.0 million, down 69.23% from the prior year.
• Asset Writedowns and Impairment improved to $4.0 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $13.0 million in Q4 2024 to a low of $1.0 million in Q4 2025.
• A 3-year average of $5.5 million and a median of $4.0 million in 2025 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2025 — Asset Writedowns and Impairment tumbled 92.31% — and 2026, when it changed 0.0%.
• Tracing RXO's Asset Writedowns and Impairment over 3 years: stood at $13.0 million in 2024, then plunged by 92.31% to $1.0 million in 2025, then jumped by 300.0% to $4.0 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $4.0 million (Q1 2026), $1.0 million (Q4 2025), and $4.0 million (Q1 2025), per Business Quant data.